Kolon TissueGene, Inc. (KOSDAQ:950160)
11,740
-400 (-3.29%)
Nov 20, 2026, 3:30 PM KST
Kolon TissueGene Market Cap
Kolon TissueGene has a market cap or net worth of 997.55 billion as of November 20, 2026. It is the 11,193rd most valuable company in the world and the 281st biggest in South Korea. Its market cap has decreased by 77.72% in one year.
Market Cap
997.55B
Enterprise Value
964.99B
Revenue
4.80B
Global Rank
Country Rank
#281 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since November 6, 2017, Kolon TissueGene's market cap has decreased from 2.58T to 997.55B, a decrease of -61.31%. That is a compound annual growth rate of -9.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 997.55B | -84.94% |
| Dec 30, 2025 | 6.62T | 258.54% |
| Dec 30, 2024 | 1.85T | 181.73% |
| Dec 28, 2023 | 655.80B | 7.08% |
| Dec 29, 2022 | 612.43B | -76.74% |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Peptron | 2.01T |
| ABL Bio | 1.97T |
| LigaChem Biosciences | 1.92T |
| Voronoi | 1.91T |
| OliX Pharmaceuticals | 1.76T |
| D&D Pharmatech | 1.55T |
| Chabiotech | 676.19B |
| Proteina | 645.56B |